BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11089242)

  • 1. Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae.
    Woo MH; Vance JR; Bjornsti MA
    Methods Mol Biol; 2001; 95():303-13. PubMed ID: 11089242
    [No Abstract]   [Full Text] [Related]  

  • 2. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
    Nitiss JL; Nitiss KC
    Methods Mol Biol; 2001; 95():315-27. PubMed ID: 11089243
    [No Abstract]   [Full Text] [Related]  

  • 3. Using yeast to understand drugs that target topoisomerases.
    Nitiss JL; Rose A; Sykes KC; Harris J; Zhou J
    Ann N Y Acad Sci; 1996 Dec; 803():32-43. PubMed ID: 8993498
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug toxicity in E. coli cells expressing human topoisomerase I.
    Taylor ST; Menzel R
    Methods Mol Biol; 2001; 95():195-204. PubMed ID: 11089232
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.
    Bjornsti MA; Benedetti P; Viglianti GA; Wang JC
    Cancer Res; 1989 Nov; 49(22):6318-23. PubMed ID: 2553253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
    Nitiss J; Wang JC
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7501-5. PubMed ID: 2845409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I.
    Edwards TK; Saleem A; Shaman JA; Dennis T; Gerigk C; Oliveros E; Gartenberg MR; Rubin EH
    J Biol Chem; 2000 Nov; 275(46):36181-8. PubMed ID: 10967121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
    Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.
    Bjornsti MA; Knab AM; Benedetti P
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S1-5. PubMed ID: 8070016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human topoisomerase I mediates illegitimate recombination leading to DNA insertion into the ribosomal DNA locus in Saccharomyces cerevisiae.
    Zhu J; Schiestl RH
    Mol Genet Genomics; 2004 Apr; 271(3):347-58. PubMed ID: 15007730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.
    Pouliot JJ; Yao KC; Robertson CA; Nash HA
    Science; 1999 Oct; 286(5439):552-5. PubMed ID: 10521354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of DNA topoisomerase I-induced cell killing in the yeast Saccharomyces cerevisiae.
    Fiorani P; Bjornsti MA
    Ann N Y Acad Sci; 2000; 922():65-75. PubMed ID: 11193926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression and purification of DNA topoisomerase I from yeast.
    Bjornsti MA; Fertala J
    Methods Mol Biol; 1999; 94():179-86. PubMed ID: 12844874
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel selective inhibitors for human topoisomerase I, BM2419-1 and -2 derived from saintopin.
    Ishiyama D; Futamata K; Futamata M; Kasuya O; Kamo S; Yamashita F; Kanazawa S
    J Antibiot (Tokyo); 1998 Dec; 51(12):1069-74. PubMed ID: 10048564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs.
    Reid RJ; Benedetti P; Bjornsti MA
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):289-300. PubMed ID: 9748633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast as a genetic model system for studying topoisomerase inhibitors.
    Nitiss JL
    Adv Pharmacol; 1994; 29B():201-26. PubMed ID: 8996609
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
    Eng WK; Faucette L; Johnson RK; Sternglanz R
    Mol Pharmacol; 1988 Dec; 34(6):755-60. PubMed ID: 2849043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced stabilization of covalent DNA topoisomerase I-DNA intermediates. DNA cleavage assays.
    Fiorani P; Hann CL; Benedetti P; Bjornsti MA
    Methods Mol Biol; 2001; 95():291-301. PubMed ID: 11089241
    [No Abstract]   [Full Text] [Related]  

  • 19. On the relationship of the ATP-independent, mitochondrial associated DNA topoisomerase of Saccharomyces cerevisiae to the nuclear topoisomerase I.
    Wang J; Kearney K; Derby M; Wernette CM
    Biochem Biophys Res Commun; 1995 Sep; 214(2):723-9. PubMed ID: 7677787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors.
    Lotito L; Russo A; Bueno S; Chillemi G; Fogli MV; Capranico G
    Eur J Pharmacol; 2009 Jan; 603(1-3):29-36. PubMed ID: 19094980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.